Displaying 1–25 of 77 results for Contract Service
The Trump administration announced that the federal government would sharply limit federal spending on medical research that uses tissue from aborted fetuses.
In a bombshell testimony before Congress, President Trump’s ex-lawyer Michael Cohen described the details of a deal he made with Novartis, which wanted him to lobby for the company and provide access to the White House.
The transaction, which was announced last November, aims to strengthen the manufacturer of small molecule and generic APIs in its position in early stage small molecule development and testing services.
Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network
Abbvie is claiming England's National Health Service (NHS) breached procurement rules during the process of seeking suppliers for hepatitis C treatment.
Novartis announced the sale of its Quebec sterile manufacturing facility as well as its Sandoz Development Center to CDMO Avara Pharmaceutical Services.
Shortly after the election of President Trump, the Novartis entered into a one year agreement with Essential Consultants, hoping that Michael Cohen could advise the company as to how the Trump administration might approach certain U.S. healthcare policy matters, including the Affordable Care Act.
The Bausch+Ströbel filler can fill 200 vials per minute and will more than triple GRAM’s manufacturing capacity.
Industry experts from bioLIVE say integration of supply chain will be a critical issue as industry globalizes, with a resurgence in European manufacturing and biotech markets forecast
Quotient Clinical, the drug development services organization, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research.
The suit says that J&J’s exclusionary contracts and anticompetitive practices have denied patients access to therapeutic options and undermined price competition.
Bristol-Myers Squibb will sell its active pharmaceutical ingredients manufacturing facility in Swords, Co Dublin to SK Biotek, a south Korean biotechnology firm.
Taking pharma sourcing and procurement to the next level
Capsugel's Installation of state-of-the-art Harro Hӧfliger encapsulation unit expands clinical- and commercial-scale capacity for dry powder inhalation applications
The new jobs will be in the sciences, clinical services and clinical technologies and pharmaceutical services
The CPhI Pharma Awards Gala took place on Tuesday 4th October in Barcelona,
FDA cites Elite Pharma for inadequate reporting of adverse drug experiences
The merger creates a cell and gene therapy biologics contract development and manufacturing organization
The site will offer clinical supply solutions to meet the needs of both domestic and global clinical trial sponsors
Both Xcelience and Powdersize will be integrated with Capsugel’s Dosage Form Solutions business unit
Authorized Economic Operator FullRecognizes Company’s Operational Excellence
David Mayers has been appointed president of WellSpring Pharma Services
The business will be located in its 32,000-square-foot, FDA-inspected and cGMP-compliant facility